Prevalence and Risk Factors for Abdominal Bloating and Visible Distention: a Population-based Study

Overview

Journal Gut

Specialty Gastroenterology

Date 2008 May 15

PMID 18477677

Citations 45

Authors

X Jiang

G R Locke 3rd

R S Choung

A R Zinsmeister

C D Schleck

N J Talley

Affiliations

Soon will be listed here.

Abstract

Background: Abdominal bloating and visible distention are common yet poorly understood symptoms. Epidemiological data distinguishing visible distention from bloating are not available. We aimed to evaluate the prevalence and potential risk factors for abdominal bloating and visible distention separately in a representative US population, and their association with other functional gastrointestinal disorders (FGIDs).

Methods: The validated Talley Bowel Disease Questionnaire was mailed to a cohort selected at random from the population of Olmsted County, Minnesota. The complete medical records of responders were abstracted; 2259 subjects (53% females; mean age 62 years) provided bloating and distention data.

Results: The age and sex-adjusted (US White 2000) overall prevalence per 100 for bloating was 19.0 [95% confidence interval (CI), 16.9 to 21.2] vs 8.9 (95% CI, 7.2 to 10.6) for visible distention. Significantly increased odds for bloating alone and separately for distention (vs neither) were detected in females, and in those with higher overall Somatic Symptom Checklist (SSC) scores and higher scores of each individual SSC item. Further, females [odds ratio (OR), 1.5; 95% CI, 1.0 to 2.1], higher SSC score (OR, 1.4; 95% CI, 1.1 to 1.8), constipation-predominant irritable bowel syndrome (OR, 2.3; 95% CI, 1.3 to 4.1), dyspepsia (OR, 1.9; 95% CI, 1.1 to 3.2), and gastro-intestinal symptom complex overlap (OR, 1.7; 95% CI, 1.1 to 2.7) significantly increased odds for distention over bloating alone.

Conclusions: Bloating and distention are common and have similar risk factors; somatisation probably plays a role.

Citing Articles

Analysis of the incidence and influencing factors of abdominal distension in postoperative lung cancer patients in ICU based on real-world data: a retrospective cohort study.

Liu Y, Tang T, Wang C, Wang C, Zhu D BMC Surg. 2024; 24(1):26.

PMID: 38238695 PMC: 10795388. DOI: 10.1186/s12893-024-02317-2.

The Disease Spectrum and Natural History of Patients With Abdominal Bloating or Distension: A Longitudinal Study.

Chen F, Tan N, Chen S, Zhuang Q, Zhang M, Xiao Y J Neurogastroenterol Motil. 2024; 30(1):64-72.

PMID: 38173159 PMC: 10774809. DOI: 10.5056/jnm22197.

Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.

Petrisor D, Etropolska Z, Elenski K, Dimitrova E, Santos J Dig Dis Sci. 2023; 69(1):161-168.

PMID: 37923826 PMC: 10787906. DOI: 10.1007/s10620-023-08155-1.

Prevalence and Associated Factors of Bloating: Results From the Rome Foundation Global Epidemiology Study.

Ballou S, Singh P, Nee J, Rangan V, Iturrino J, Geeganage G Gastroenterology. 2023; 165(3):647-655.e4.

PMID: 37315866 PMC: 10527500. DOI: 10.1053/j.gastro.2023.05.049.

A Tritordeum-Based Diet for Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Effects on Abdominal Bloating and Psychological Symptoms.

Riezzo G, Prospero L, Orlando A, Linsalata M, DAttoma B, Ignazzi A Nutrients. 2023; 15(6).

PMID: 36986090 PMC: 10056490. DOI: 10.3390/nu15061361.

References

Skoog S, Bharucha A . Dietary fructose and gastrointestinal symptoms: a review. Am J Gastroenterol. 2004; 99(10):2046-50. DOI: 10.1111/j.1572-0241.2004.40266.x. View

Talley N, Fett S, Zinsmeister A, Melton 3rd L . Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology. 1994; 107(4):1040-9. DOI: 10.1016/0016-5085(94)90228-3. View

Melton 3rd L . History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996; 71(3):266-74. DOI: 10.4065/71.3.266. View

Saito Y, Locke G, Talley N, Zinsmeister A, Fett S, Melton 3rd L . A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000; 95(10):2816-24. DOI: 10.1111/j.1572-0241.2000.03192.x. View

Chang L, Lee O, Naliboff B, Schmulson M, Mayer E . Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol. 2002; 96(12):3341-7. DOI: 10.1111/j.1572-0241.2001.05336.x. View

Malacara J . Association of physical and emotional symptoms with the menstrual cycle and life-style. J Reprod Med. 1993; 38(6):448-54. View

Talley N, Quan C, Jones M, Horowitz M . Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004; 16(4):413-9. DOI: 10.1111/j.1365-2982.2004.00530.x. View

Richard Locke 3rd G, Weaver A, Melton 3rd L, Talley N . Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol. 2004; 99(2):350-7. DOI: 10.1111/j.1572-0241.2004.04043.x. View

Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E . Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol. 2000; 12(9):981-8. DOI: 10.1097/00042737-200012090-00003. View

10.

Smith R, GREENBAUM D, Vancouver J, Henry R, Reinhart M, Greenbaum R . Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology. 1991; 100(3):591-5. DOI: 10.1016/0016-5085(91)80002-q. View

11.

Heitkemper M, Cain K, Jarrett M, Burr R, Hertig V, Bond E . Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol. 2003; 98(2):420-30. DOI: 10.1111/j.1572-0241.2003.07233.x. View

12.

Lewis M, Reilly B, Houghton L, Whorwell P . Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut. 2001; 48(2):216-20. PMC: 1728192. DOI: 10.1136/gut.48.2.216. View

13.

Bijkerk C, Muris J, Knottnerus J, Hoes A, de Wit N . Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004; 19(3):245-51. DOI: 10.1111/j.0269-2813.2004.01862.x. View

14.

Serra J, Azpiroz F, Malagelada J . Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut. 2000; 48(1):14-9. PMC: 1728167. DOI: 10.1136/gut.48.1.14. View

15.

Sandler R, Stewart W, Liberman J, Ricci J, Zorich N . Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci. 2000; 45(6):1166-71. DOI: 10.1023/a:1005554103531. View

16.

Caldarella M, Serra J, Azpiroz F, Malagelada J . Prokinetic effects in patients with intestinal gas retention. Gastroenterology. 2002; 122(7):1748-55. DOI: 10.1053/gast.2002.33658. View

17.

Sullivan S . A prospective study of unexplained visible abdominal bloating. N Z Med J. 1994; 107(988):428-30. View

18.

Ustun B, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S . WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend. 1997; 47(3):161-9. DOI: 10.1016/s0376-8716(97)00087-2. View

19.

Houghton L, Lea R, Jackson N, Whorwell P . The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut. 2002; 50(4):471-4. PMC: 1773170. DOI: 10.1136/gut.50.4.471. View

20.

Talley N, Stanghellini V, Heading R, Koch K, Malagelada J, Tytgat G . Functional gastroduodenal disorders. Gut. 1999; 45 Suppl 2:II37-42. PMC: 1766695. DOI: 10.1136/gut.45.2008.ii37. View